Inhibition of mTOR down-regulates scavenger receptor, class B, type I (SR-BI) expression, reduces endothelial cell migration and impairs nitric oxide production

The mammalian target of rapamycin (mTOR) inhibiting drug rapamycin (Sirolimus) has severe side effects in patients including hyperlipidemia, an established risk factor for atherosclerosis. Recently, it was shown that rapamycin decreases hepatic LDL receptor (LDL-R) expression, which likely contribut...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biochim Biophys Acta Mol Cell Biol Lipids
Main Authors: Fruhwürth, Stefanie, Krieger, Sigurd, Winter, Katharina, Rosner, Margit, Mikula, Mario, Weichhart, Thomas, Bittman, Robert, Hengstschläger, Markus, Stangl, Herbert
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487575/
https://ncbi.nlm.nih.gov/pubmed/24713582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2014.03.014
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker